Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,003 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04562480 | Radiation Therapy Before Surgery for Localized, Resectable Soft Tissue Sarcoma of the Extremity and Superficial Trunk | active not recruiting | Phase 2 | 120 | Mayo ClinicOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT06053333 | Social Determinants of Health in Hepatobiliary Cancer Patients | recruiting | — | 400 | Mayo ClinicOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT06472804 |
| Insomnia in Patients With Metastatic Lung Cancer |
| recruiting |
| — |
| 60 |
| Mayo ClinicOTHER |
| 1 |
| Feb 4, 2026 |
| clinicaltrials |
| NCT04799535 | Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring | recruiting | — | 550 | Mayo ClinicOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT05918185 | Evaluation of Comprehensive Geriatric Assessment and Laboratory Biomarkers in Elderly Patients With Multiple Myeloma | completed | — | 56 | Mayo ClinicOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT06470711 | Mapping of Electrical Properties in the Brain | recruiting | — | 120 | Mayo ClinicOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT07280312 | Ultrasound Microvessel Imaging for the Evaluation of Ovarian and Adnexal Lesions | recruiting | N/A | 40 | Mayo ClinicOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT04323956 | Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma | active not recruiting | Phase 1 | 50 | Mayo ClinicOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT07381179 | Voices: Messages of Wisdom and Hope in the Face of Illness | recruiting | — | 40 | Mayo ClinicOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT05584449 | Group Curriculum for Improving Survivorship Outcomes in Adolescent and Young Adult Cancer Survivors | recruiting | N/A | 60 | Mayo ClinicOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT03564483 | Gynecologic Extramammary Paget's Disease | recruiting | — | 100 | Mayo ClinicOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT03865212 | Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma | terminated | Phase 1 | 12 | Mayo ClinicOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT06834373 | Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy | recruiting | Phase 2 | 41 | Mayo ClinicOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT03961945 | Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma | recruiting | N/A | 1,550 | Mayo ClinicOTHER | 1 | Jan 26, 2026 | clinicaltrials |
| NCT04341012 | Breath Analysis Based Disease Biomarkers | completed | — | 46 | Mayo ClinicOTHER | 1 | Jan 26, 2026 | clinicaltrials |
| NCT05979883 | Randomized Evaluation of Machine Learning Assisted Radiation Treatment Planning vs Standard Radiation Treatment Planning | completed | N/A | 204 | Mayo ClinicOTHER | 1 | Jan 26, 2026 | clinicaltrials |
| NCT06126796 | Urine-based Molecular Testing vs Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer (NMIBC) | completed | — | 107 | Mayo ClinicOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT07358208 | Prospective Familial Registry for Pancreas Research(PARTNER) | enrolling by invitation | — | 3,000 | Mayo ClinicOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT06508034 | Probiotics for the Prevention of Immunotherapy Induced Colitis in Patients Receiving Immunotherapy | suspended | N/A | 12 | Mayo ClinicOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT04118660 | Thoracic Specimen Registry | recruiting | — | 7,000 | Mayo ClinicOTHER | 1 | Jan 16, 2026 | clinicaltrials |
| NCT04443413 | Phase III Study of 5tx vs 15tx of RT (X-rays or Protons) Including RNI in Breast Cancer Patients | active not recruiting | Phase 3 | 146 | Mayo ClinicOTHER | 1 | Jan 16, 2026 | clinicaltrials |
| NCT05388058 | Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy | completed | Phase 2 | 40 | Mayo ClinicOTHER | 1 | Jan 16, 2026 | clinicaltrials |
| NCT04474821 | HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults | completed | Phase 4 | 100 | Mayo ClinicOTHER | 1 | Jan 12, 2026 | clinicaltrials |
| NCT05465954 | Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma | recruiting | Phase 2 | 54 | Mayo ClinicOTHER | 1 | Jan 12, 2026 | clinicaltrials |
| NCT02917759 | Liver and Biliary Tumor Tissue Registry | terminated | — | 1,000 | Mayo ClinicOTHER | 1 | Jan 9, 2026 | clinicaltrials |
| NCT03017794 | Evaluation of Neuroendocrine Differentiation as a Potential Mechanism of Tumor Recurrence Following Radiotherapy | active not recruiting | — | 118 | Mayo ClinicOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT05600283 | Patient Self-sampling of HPV to Screen for Cervical Cancer | completed | N/A | 222 | Mayo ClinicOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT04805788 | Stereotactic Body Proton Radiotherapy for the Treatment of Liver Cancer | terminated | Phase 2 | 9 | Mayo ClinicOTHER | 1 | Dec 31, 2025 | clinicaltrials |
| NCT04230304 | Daratumumab and Ibrutinib for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia, DIRECT Study | terminated | Phase 2 | 8 | Mayo ClinicOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT04999826 | Multiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer Survivors | completed | — | 105 | Mayo ClinicOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT06420349 | NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma | terminated | Phase 1 | 7 | Mayo ClinicOTHER | 1 | Dec 22, 2025 | clinicaltrials |
| NCT05407025 | Targeting Inflammation for Endometrial Cancer Prevention | active not recruiting | — | 191 | Mayo ClinicOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT02600156 | Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors | completed | N/A | 7 | Mayo ClinicOTHER | 1 | Dec 17, 2025 | clinicaltrials |
| NCT06347809 | DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine | terminated | — | 24 | Mayo ClinicOTHER | 1 | Dec 15, 2025 | clinicaltrials |
| NCT02364713 | MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer | terminated | Phase 2 | 17 | Mayo ClinicOTHER | 1 | Dec 11, 2025 | clinicaltrials |
| NCT02872532 | Testicular Tissue Cryopreservation in Children | recruiting | N/A | 200 | Mayo ClinicOTHER | 1 | Dec 8, 2025 | clinicaltrials |
| NCT02783690 | A Trial of 15 Fraction vs 25 Fraction Pencil Beam Scanning Proton Radiotherapy After Mastectomy in Patients Requiring Regional Nodal Irradiation | completed | Phase 2 | 88 | Mayo ClinicOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT06870539 | Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment | completed | — | 49 | Mayo ClinicOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT04620369 | Rose Geranium in Sesame Oil Nasal Spray for the Improvement of Nasal Vestibulitis Symptoms in Cancer Patients Receiving Chemotherapy | completed | Phase 3 | 106 | Mayo ClinicOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT05393713 | Intra-Lymphatic STI-3031 Using the Sofusa DoseConnect Device for Treatment of In-Transit Melanoma, The Sofusa-2 Study | terminated | Phase 1 | 3 | Mayo ClinicOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT03132532 | Platinum Doublet Chemotherapy and Proton Beam Radiation Therapy in Treating Patients With Stage II-III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery | completed | Phase 2 | 20 | Mayo ClinicOTHER | 1 | Nov 25, 2025 | clinicaltrials |
| NCT04783038 | Determining The Impact Of Distance Reiki On Patient Reported QOL And Immunity Among Multiple Myeloma Patients | completed | N/A | 30 | Mayo ClinicOTHER | 1 | Nov 21, 2025 | clinicaltrials |
| NCT01946100 | Treatment of Multifocal Lung Adenocarcinoma | terminated | N/A | 100 | Mayo ClinicOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT05889988 | A Study of Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients | active not recruiting | — | 36 | Mayo ClinicOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT04828486 | Futibatinib and Pembrolizumab for Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer | completed | Phase 2 | 14 | Mayo ClinicOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT06723015 | Tau PET Outcomes With Anti-amyloid Immunotherapies | enrolling by invitation | Phase 2 | 135 | Mayo ClinicOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT04396535 | Docetaxel With or Without Bintrafusp Alfa for the Treatment of Advanced Non-small Cell Lung Cancer | terminated | Phase 2 | 10 | Mayo ClinicOTHER | 1 | Nov 17, 2025 | clinicaltrials |
| NCT03979508 | Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer | terminated | Phase 2 | 26 | Mayo ClinicOTHER | 1 | Nov 12, 2025 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials